BioMarin Pharmaceutical Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for BioMarin Pharmaceutical Inc. (BMRN) is 14.45B

According to BioMarin Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.45B. This represents a change of 28.58% compared to the average of 11.24B of the last 4 quarters.

BioMarin Pharmaceutical Inc. (BMRN) Historical Enterprise Value (quarterly & annually)

How has BMRN Enterprise Value performed in the past?

The mean historical Enterprise Value of BioMarin Pharmaceutical Inc. over the last ten years is 15.50B. The current 14.45B Enterprise Value has changed -6.79% with respect to the historical average. Over the past ten years (40 quarters), BMRN's Enterprise Value was at its highest in in the June 2020 quarter at 22.93B. The Enterprise Value was at its lowest in in the September 2025 quarter at 9.75B.

BioMarin Pharmaceutical Inc. (BMRN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioMarin Pharmaceutical Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioMarin Pharmaceutical Inc. (BMRN) Average Enterprise Value

How has BMRN Enterprise Value performed in the past?

The current Enterprise Value of BioMarin Pharmaceutical Inc. (BMRN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

BioMarin Pharmaceutical Inc. (BMRN) Enterprise Value vs. Peers

How is BMRN’s Enterprise Value compared to its peers?

BioMarin Pharmaceutical Inc.’s Enterprise Value is greater than Ultragenyx Pharmaceutical Inc. (2.68B), greater than Ionis Pharmaceuticals, Inc. (8.92B), less than BridgeBio Pharma, Inc. (15.57B), greater than PTC Therapeutics, Inc. (5.21B), greater than Travere Therapeutics, Inc. (5.14B), greater than Ascendis Pharma A/S (14.27B), greater than Pharming Group N.V. (815.35M), less than Alnylam Pharmaceuticals, Inc. (20.67B), less than Vertex Pharmaceuticals Incorporated (136.04B), less than Insmed Incorporated (24.33B),

Build a custom stock screener for BioMarin Pharmaceutical Inc. (BMRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMarin Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioMarin Pharmaceutical Inc. (BMRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioMarin Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.